Home Cart Sign in  
Chemical Structure| 834903-43-4 Chemical Structure| 834903-43-4

Structure of CID 16020046
CAS No.: 834903-43-4

Chemical Structure| 834903-43-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CID-16020046 is a selective GPR55 (LPI receptor) antagonist with IC50 of 0.15 μM.

Synonyms: C390-0219

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CID 16020046

CAS No. :834903-43-4
Formula : C25H19N3O4
M.W : 425.44
SMILES Code : O=C(N1C(C=C2)=CC=C2C(O)=O)C(NN=C3C4=CC=C(C)C=C4)=C3C1C5=CC(O)=CC=C5
Synonyms :
C390-0219
MDL No. :MFCD06196075
InChI Key :VGUQVYZXABOXCX-UHFFFAOYSA-N
Pubchem ID :16020046

Safety of CID 16020046

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Related Pathways of CID 16020046

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 cells 1μM 24 h Enhanced cytotoxicity of doxorubicin Pharmacol Res. 2016 Sep;111:757-766
U87MG cells 1μM 24 h Enhanced cytotoxicity of doxorubicin Pharmacol Res. 2016 Sep;111:757-766
rat mesenteric artery endothelial cells 2.5 µM To investigate the effect of CID 16020046 on LPI-induced vasorelaxation. The results showed that CID 16020046 significantly reduced LPI-induced vasorelaxation Br J Pharmacol. 2015 Jun;172(12):3043-57
PANC-1 cells 1μM 24 h Reduced MDR protein expression and enhanced cytotoxicity of chemotherapeutic drugs Pharmacol Res. 2016 Sep;111:757-766

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Antiretroviral-induced neuropathic pain model Intraperitoneal injection 10 mg/kg Single administration, experiment lasted up to 70 minutes post-administration To evaluate the effect of GPR55 antagonist CID 16020046 on the antihyperalgesic activity of 2-AG. Results showed that CID 16020046 significantly antagonized the antihyperalgesic effect of 2-AG. Front Pharmacol. 2017 Mar 20;8:136

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.24mL

11.75mL

2.35mL

1.18mL

23.51mL

4.70mL

2.35mL

References

 

Historical Records

Categories